Genprex Extends Licenses from MD Anderson

Genprex Extends Licenses from MD Anderson

Genprex (NASDAQ:GNPX) has entered into amendments with The University of Texas MD Anderson Cancer Center to extend the terms of two option agreements pertaining the use of TUSC2, the active agent in Genprex’s Oncoprex, in combination with immunotherapies and the...

Pin It on Pinterest